GSK (NYSE:GSK – Get Free Report) was downgraded by investment analysts at StockNews.com from a “strong-buy” rating to a “buy” ...

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! LONDON, GREATER LONDON , UNITED KINGDOM, January 23, 2025 /EINPresswire / -- What's ...

Natural capital went mainstream in 2024, with biodiversity bonds hitting new highs and record shareholder resolutions on ...

There are now over 110,000 employees working for Sanofi in over 100 countries, which includes the United Kingdom ... which it later sold to GlaxoSmithKline who marketed the drug as Thorazine.

The new facility at Stainton, near Barnard Castle, will power the nearby Glaxo Smith Kline factory for 40 years ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

GlaxoSmithKline is investing in artificial intelligence (AI) with the hope of radically cutting the time and money needed to develop a drug. It has entered into an alliance with Exscientia, a new ...

Teva Pharmaceutical Industries Ltd. ADR-0.46% $24.97B ...

After hours: January 17 at 7:25:46 p.m. EST ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Interstitial Lung Disease ...

Launched in September 2024, the Investor & Issuer Forum (I&IF) is an expansion of the Investor Forum, a low profile but ...